Prospective trial of minimal residual disease assessment by multiparametric flow cytometry for multiple myeloma in the era of bortezomib-based chemotherapy

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION(2018)

引用 0|浏览18
暂无评分
关键词
Disease-free survival,Stem-cell therapies,Medicine/Public Health,general,Internal Medicine,Cell Biology,Public Health,Hematology,Stem Cells
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要